SatinexTM is formulated by Yasdaru Pharmaceutical Inc. Iran, by Accelerated Solvent Extractor (ASE) method in the form of buccal spray using a natural extract of a native cloned phenotype obtained during our breeding programs. SatinexTM active substance contains 2.7 mg of Δ9-THC and 2.5 mg of CBD in a 1:1 ratio.

SatinexTM is prescribed in MS patients to relieve muscle stiffness and neuropathic pain and sleep disturbances.